Aberrant expression of annexin A2-SI00A10 heterotetramer （AIIt） associated with PML/RARα fusion protein causes lethal hyperfibrinolysis in acute promyelocytic leukemia （APL）, but the mechanism is unclear. To faci...Aberrant expression of annexin A2-SI00A10 heterotetramer （AIIt） associated with PML/RARα fusion protein causes lethal hyperfibrinolysis in acute promyelocytic leukemia （APL）, but the mechanism is unclear. To facilitate the investigation of regulatory association between ANXA2 and promyelocytic leukemia/retinoic acid receptor α （PML/RARα） fusion protein, this work was performed to determine the transcription start site of ANXA2 promoter with rapid amplification of 5＇-cDNA ends analysis. Zinc-induced U937/PR9 cells expressed PML/RARα fusion protein, and resultant increases in ANXA2 transcripts and translational expressions of both ANXA2 and S100A10, while S100A10 transcripts remained constitutive. The transactivation of ANXA2 promoter by PML/RARα fusion protein was 3.29 ± 0.13 fold higher than that by control pSG5 vector or wild-type RARer. The overexpression of ANXA2 in U937 transfected with full-length ANXA2 cDNA was associated with increased S100A10 subunit, although S100A10 transcripts remained constitutive. The tPA-dependent initial rate of plasmin generation （IRPG） in zinc-treated U937/PR9 increased by 2.13-fold, and cell invasiveness increased by 27.6%. Antibodies against ANXA2, S100A10, or combination of both all remarkably inhibited the IRPG and invasiveness in U937/PR9 and NB4. Treatment of zinc-induced U937/PR9 or circulating APL blasts with all-trans retinoic acid （ATRA） significantly reduced cell surface ANXA2 and S100A10 and associated reductions in IRPG and invasiveness. Thus, PML/RARα fusion protein transactivated the ANXA2 promoter to upregulate ANXA2 and accumulate S100A10. Increased AIIt promoted IRPG and invasiveness, both of which were partly abolished by antibodies against ANXA2 and S100A10 or by ATRA.展开更多
文摘【目的】从鸡卵泡膜细胞蛋白中筛选和鉴定与膜联蛋白A2(ANXA2)相互作用的细胞蛋白并进行功能分析,为深入研究ANXA2调控鸡卵泡发育的作用机制提供理论依据。【方法】制备开产后30周龄贵州黄鸡的卵泡膜细胞,提取卵泡膜总蛋白后利用His Pull-Down联合质谱技术(LC-MS/MS)从卵泡膜细胞中筛选出与鸡ANXA2互作的细胞蛋白,然后通过GO数据库和KEEG数据库分别进行GO功能富集分析及KEEG信号通路注释分析,并利用STRING Version 11.0绘制蛋白互作网络图。【结果】通过His Pull-Down联合LC-MS/MS共鉴定获得41个鸡ANXA2互作细胞蛋白,GO功能富集分析发现这些互作细胞蛋白在分子功能、生物学进程和细胞组成均发挥作用。其中,在分子功能方面主要涉及蛋白结合(占58.06%)、催化活性(占19.35%)、核糖体结构(占16.13%)及细胞骨架结构组成(占6.45%),在生物学进程方面主要参与细胞骨架(占19.35%)、刺激反应(占19.35%)、翻译(占16.13%)、代谢过程(占12.90%)、细胞迁移(占12.90%)、蛋白折叠(占9.68%)和蛋白运输(占9.68%),而细胞组分显示以定位于细胞膜的蛋白为主(占32.26%)。鸡ANXA2蛋白互作细胞蛋白参与的KEEG信号通路主要有应激反应、代谢、翻译、信号转导、免疫系统和蛋白定位等。鸡ANXA2互作细胞蛋白互作网络可分为3条,即CNN2-FN1-MYH9-MYH10-ACTN1-CSRP1、ANXA1-ANXA2-ENO1-PRDX4-GPI-ATP5B-PRDX3-HSPA8-TUBB2A和CCT7-CCT4-GNB2L1-ATP5A1-RPS3-RPS3A-RPL23A-RPL22-RPS7;互作细胞蛋白间存在复杂的互作关系,其中又以膜联蛋白A1(ANXA1)与烯醇化酶-1(ENO1)及ANXA2的互作关系最明显。【结论】鸡ANXA2互作细胞蛋白主要参与细胞骨架形成、应对刺激和翻译等生物学过程,涉及应激反应、代谢、翻译、信号转导、免疫及蛋白定位等信号通路。其中,PRDX3、PRDX4、MYH9和TCSC可能通过与ANXA2蛋白相互作用而参与鸡卵巢相关疾病的发生,而ANXA1与ANXA2相互作用可能在鸡卵泡的发育及排卵过程中发挥重要调节作用。
文摘Aberrant expression of annexin A2-SI00A10 heterotetramer （AIIt） associated with PML/RARα fusion protein causes lethal hyperfibrinolysis in acute promyelocytic leukemia （APL）, but the mechanism is unclear. To facilitate the investigation of regulatory association between ANXA2 and promyelocytic leukemia/retinoic acid receptor α （PML/RARα） fusion protein, this work was performed to determine the transcription start site of ANXA2 promoter with rapid amplification of 5＇-cDNA ends analysis. Zinc-induced U937/PR9 cells expressed PML/RARα fusion protein, and resultant increases in ANXA2 transcripts and translational expressions of both ANXA2 and S100A10, while S100A10 transcripts remained constitutive. The transactivation of ANXA2 promoter by PML/RARα fusion protein was 3.29 ± 0.13 fold higher than that by control pSG5 vector or wild-type RARer. The overexpression of ANXA2 in U937 transfected with full-length ANXA2 cDNA was associated with increased S100A10 subunit, although S100A10 transcripts remained constitutive. The tPA-dependent initial rate of plasmin generation （IRPG） in zinc-treated U937/PR9 increased by 2.13-fold, and cell invasiveness increased by 27.6%. Antibodies against ANXA2, S100A10, or combination of both all remarkably inhibited the IRPG and invasiveness in U937/PR9 and NB4. Treatment of zinc-induced U937/PR9 or circulating APL blasts with all-trans retinoic acid （ATRA） significantly reduced cell surface ANXA2 and S100A10 and associated reductions in IRPG and invasiveness. Thus, PML/RARα fusion protein transactivated the ANXA2 promoter to upregulate ANXA2 and accumulate S100A10. Increased AIIt promoted IRPG and invasiveness, both of which were partly abolished by antibodies against ANXA2 and S100A10 or by ATRA.
